| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2007;50:212.)
© 2007 American Heart Association, Inc.
Sixth International Workshop on Structure and Function of the Vascular System |
From the Institut National de la Santé et de la Recherche Médicale (INSERM) U689 (C.D., B.E., I.L., A.T., S.L.), Centre de Recherche Cardiovasculaire Inserm Lariboisière, Paris, France; INSERM U702 (M.F., S.P., C.C., J-C.D.), Hôpital Tenon, Université Pierre et Marie Curie, Paris, France; and the Department of Physiology (J-C.D.), Hôpital St-Antoine, Paris, France.
Correspondence to Stéphanie Lehoux, Centre de Recherche Cardiovasculaire Inserm Lariboisière, INSERM U689, 41 Boulevard de la Chapelle, 75010 Paris, France. E-mail lehoux{at}larib.inserm.fr
Hypertension is associated with vascular remodeling characterized by rearrangement of extracellular matrix proteins. To evaluate how matrix metalloproteinase (MMP)-9 contributes to the progression of hypertensive vascular disease in vivo, wild-type (wt) or MMP-9/ mice were treated with angiotensin II (Ang II; 1 µg/kg per minute, by minipump) plus a 5% NaCl diet during 10 days. Baseline blood pressure was equivalent in wt and knockout mice, but Ang II treatment increased systolic blood pressure to a greater extent (P<0.05) in MMP-9/ mice (94±6 to 134±6 mm Hg; P<0.001) than in wt animals (93±4 to 114±6 mm Hg; P<0.01). In wt mice, Ang II treatment increased the carotid artery pressure-diameter relationship significantly, and maximal diameter reached 981±19 µm (P<0.01 versus sham; 891±10 µm). In contrast, in MMP-9/ mice, carotid artery compliance was actually reduced after Ang II (P<0.05), and maximal diameter only reached 878±13 µm. Ang II treatment induced MMP-2 and increased carotid media thickness equally in both phenotypes. However, MMP-9 induction and in situ gelatinase activity were only enhanced in Ang II-treated wt mice, and vessels from these mice also produced more collagen I breakdown products than their MMP-9/ counterparts (P<0.05). Inversely, staining for collagen IV was particularly enhanced in vessels from MMP-9/ mice treated with Ang II. These results demonstrate the following: (1) the onset of Ang II-induced hypertension is accompanied by increased MMP-9 activity in conductance vessels; (2) absence of MMP-9 activity results in vessel stiffness and increased pulse pressure; and (3) MMP-9 activation is associated with a beneficial role early on in hypertension by preserving vessel compliance and alleviating blood pressure increase.
Key Words: angiotensin metalloproteinases remodeling hypertension collagen
This article has been cited by other articles:
![]() |
C. Arnould, M. Lelievre-Pegorier, P. Ronco, and B. Lelongt MMP9 Limits Apoptosis and Stimulates Branching Morphogenesis During Kidney Development J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2171 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ying, P. Yue, X. Xu, M. Zhong, Q. Sun, M. Mikolaj, A. Wang, R. D. Brook, L. C. Chen, and S. Rajagopalan Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1540 - H1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dhingra, M. J. Pencina, P. Schrader, T. J. Wang, D. Levy, K. Pencina, D. A. Siwik, W. S. Colucci, E. J. Benjamin, and R. S. Vasan Relations of Matrix Remodeling Biomarkers to Blood Pressure Progression and Incidence of Hypertension in the Community Circulation, March 3, 2009; 119(8): 1101 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Ruddy, J. A. Jones, F. G. Spinale, and J. S. Ikonomidis Regional heterogeneity within the aorta: Relevance to aneurysm disease. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1123 - 1130. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |